|
Prescription Drug Search
Strengths available for Asacol:
Strengths available for Asacol enema:
Strengths available for Asacol:
Strengths available for Asacol suppos.:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Asacol:
- Algeria
- Anguilla
- Antigua and Barbuda
- Australia
- Bolivia
- Bulgaria
- Costa Rica
- Croatia
- Dominican Republic
- Ecuador
- Egypt
- European Union
- Germany
- Honduras
- India
- Italy
- Jamaica
- Japan
- Korea, Republic of
- Korea, South
- Latvia
- Luxembourg
- Mauritius
- Netherlands
- New Zealand
- Norway
- Panama
- Russian Federation
- Serbia
- Singapore
- Slovenia
- Switzerland
- Taiwan
- Thailand
- Trinidad and Tobago
- Ukraine
- United Kingdom, UK
- United States, US
- Uruguay
- Vietnam
Latest news releases on Asacol:
Warner Chilcott Sues Watson Over Generic Contraceptive - Bloomberg
Warner Chilcott had $2.7 billion in revenue last year, with sales led by osteoporosis treatment Actonel, Asacol for ulcerative colitis and Loestrin 24 FE, a low-dose birth- control pill. Under federal drug law, the filing of the lawsuit prevents ...
Warner Chilcott to explore sale of company - Yahoo Finance
Warner picked up potentially attractive products with its 2009 purchase of Procter & Gamble's (PG) pharmaceuticals business, including the osteoporosis drug Actonel and the ulcerative colitis drug Asacol. Last week, sources told Reuters that the ...
Warner Chilcott Tops But Cuts View - Yahoo Finance
We note that recently Warner Chilcott suffered a huge blow regarding the 150 mg dosage of Doryx. Sales of gastroenterology product, Asacol, climbed 13% to $211 million. The increase was driven by higher sales in the U. S. aided by higher prices.
Warner Chilcott Posts Profit Despite Falling Sales; Outlook Trimmed - NASDAQ
The revised guidance assumes that generic equivalents of Asacol 400 mg and Estrace Cream products will not be approved and enter the U.S. market during 2012. Amid declining sales of Actonel and increased generic competition in the U.S., the firm ...
